These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5299179)

  • 1. [Modern therapeutic trends in burns studied in the light of some pathogenetic aspects of lesions caused by heat. Indications and limitations of an inhibitor of proteolysis. (Preliminary note)].
    Veneziani A; Santini R; PDe Panfilis G
    Minerva Chir; 1967 Sep; 22(17):1010-2. PubMed ID: 5299179
    [No Abstract]   [Full Text] [Related]  

  • 2. [New therapeutic trends in burn disease. Clinical results].
    Rubini G
    Minerva Chir; 1967 Mar; 22(6):335-44. PubMed ID: 5299104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Burns: new therapeutic orientations].
    Rubini G
    Minerva Med; 1966 Jan; 57(6):211-4. PubMed ID: 5295269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the gastrointestinal tract in burn-induced cachexia in conditions of complex therapy using contrical].
    Mullakandov SA; Kaem RI
    Biull Eksp Biol Med; 1981 Nov; 92(11):621-4. PubMed ID: 6172167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Burns in the light of A.V. Vishnevskiĭ's school of thought].
    Sologub VK; Dolgina MI; Selezneva LG
    Khirurgiia (Mosk); 1974 Sep; (9):21-6. PubMed ID: 4617802
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of the use of an inhibitor of proteolic enzymes in the treatment of burns].
    Trotti-Maina G; Boario U
    Minerva Chir; 1967 Feb; 22(4):147-53. PubMed ID: 5299001
    [No Abstract]   [Full Text] [Related]  

  • 7. [The kallikrein inhibitor in the treatment of hemophilic syndromes. (Preliminary note)].
    De Biasi R; Attanasio S
    Rass Int Clin Ter; 1968 Aug; 48(15):951-7. PubMed ID: 5304054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional and morphological changes in the gastrointestinal tract in experimental burn shock].
    Kaem RI; Mullakandov SM
    Biull Eksp Biol Med; 1981 Nov; 92(11):624-6. PubMed ID: 6172168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current methods of treatment of ocular caustic burns caused by lime].
    D'Arrigo P; Genovesi E
    Ann Ottalmol Clin Ocul; 1966 Dec; 92(12):1349-57. PubMed ID: 5302036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local & general treatment of burns: preliminary note].
    LORTHIOIR J
    Ann Chir Plast; 1959 Mar; 4(1):10-20. PubMed ID: 13637422
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of vitamin e, pentoxifylline and aprotinin on light-induced retinal injury.
    Yilmaz T; Aydemir O; Ozercan IH; Ustundağ B
    Ophthalmologica; 2007; 221(3):159-66. PubMed ID: 17440277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of proteolytic enzymes and the use of trasylol in burns].
    Koslowski L
    Med Welt; 1968 Dec; 52():2853-6. PubMed ID: 5304892
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with trasylol in burn disease].
    Galluzzi W; Rosenholz U
    Osp Ital Chir; 1969 Jul; 21(1):67-72. PubMed ID: 5314174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern therapeutic methods for burns].
    Kioleidou S
    Hell Adelphe; 1974 Oct; (54):12-6. PubMed ID: 4499479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further clinical experience on the use of trasylol in the therapy of burns and caustic injuries of the cornea and conjunctiva].
    Secchi AG; Calogero R
    Ann Ottalmol Clin Ocul; 1967 Sep; 93(9):949-52. PubMed ID: 5305577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modern principles of the pathogenetic therapy of the burn shock].
    Sidel'nikov VO; Batkin AA; Paramonov BA; Matveenko AV; Klimov AG; Tarasenko MIu; Kallistov DB; Zinov'ev EV; Admakin AL; Petrachkov SA
    Voen Med Zh; 2003 Dec; 324(12):34-9, 96. PubMed ID: 14982002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern aspects of therapy in hemorrhage shock in cirrhotics].
    Cairella M; Vecchi L
    Clin Ter; 1966 Sep; 38(6):575-8. PubMed ID: 5300734
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical aprotinin in cardiac operations: a note of caution.
    Ciçek S; Theodoro DA
    Ann Thorac Surg; 1996 Mar; 61(3):1039-40. PubMed ID: 8619685
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trasylol, a proteinase inhibitor in surgical and internal indications].
    Haberland L; Matis P
    Med Welt; 1967 Jun; 22():1367-76. PubMed ID: 5305085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.